re:partnership officially broken, page-9

Hi shaz,

acl might still get an attractive royalty, as the heparin project is at such late stage. Infact, if acl file the fda application, all a partner needs to do is market & sell it.

Today has proven that I am not a trader. I sold out on the ann, expecting to buy back in cheaper, only to pay more for 70% of my holdings.

I must focus on the big picture here. acl will be massive in a few years, or they will be taken over at a good premium.

buy & hold!